Key result
Incident herpes zoster is not associated with major cardiovascular events in adults without prior CVD.
Why the study?
Herpes zoster is associated with cardiovascular disease risk, but findings may differ by baseline risk profile and the association among adults without prior CVD warranted evaluation.
Does incident herpes zoster increase the risk of hospitalization-requiring major cardiovascular events (unstable angina, myocardial infarction, or stroke) in adults aged 50–84 years without prior cardiovascular disease?
Cohort (n=94,421)
Yes
Does incident herpes zoster increase the risk of hospitalization-requiring major cardiovascular events (unstable angina, myocardial infarction, or stroke) in adults aged 50–84 years without prior cardiovascular disease?
In a large Japanese cohort of adults aged 50–84 years free of baseline cardiovascular disease, treated herpes zoster was not associated with an increased long-term risk of severe, hospitalization-requiring cardiovascular events, although an exploratory early risk within 1–3 months (HR 2.44) was observed.
No long-term CV event link after herpes zoster in CVD-free adults; leaves open transient early risk for prospective study.
Herpes zoster (HZ) is associated with a risk of cardiovascular disease (CVD), but findings may differ according to baseline risk profiles. We evaluated the association between HZ and CVD among adults without prior CVD. We used a municipal-level health insurance database in Japan. Adults aged 50–84 years without prior CVD were included. HZ was defined using ICD-10 diagnostic codes with concurrent antiviral prescription. The primary outcome was a composite of unstable angina pectoris, myocardial infarction, or stroke requiring hospitalization. Propensity score matching was performed and Cox proportional hazards models were used to estimate hazard ratios (HRs). Sensitivity analyses were conducted in individuals with Charlson Comorbidity Index ≥ 1. After propensity score matching, 94,269 individuals (20,575 HZ cases and 73,846 controls) were included. During a median follow-up of 58 months, 1,214 (1.3%) experienced the primary outcome. HZ was not significantly associated with increased risk (HR, 1.03; 95% CI, 0.90–1.18; p = 0.66). In a sensitivity analysis, HZ showed a non-significant trend toward higher risk (HR, 1.33; 95% CI, 0.90–1.96). In adults without prior CVD, HZ was not significantly associated with CVD events. However, a possible excess risk among individuals with comorbidities could not be excluded, supporting further evaluation in higher-risk populations.
No takes yet. Share an insight, caveat, or question.
Ikegami et al. (2026) conducted a cohort in Adults without prior cardiovascular disease evaluated for herpes zoster (n=94,421). Incident herpes zoster (ICD-10 B02.2 or B02.9 with concurrent oral antiviral prescription) vs. Age-, sex-, and propensity score-matched individuals without herpes zoster was evaluated on Composite of unstable angina pectoris, myocardial infarction, or stroke requiring hospitalization (HR 1.03, 95% CI 0.90-1.18, p=0.66). Incident herpes zoster was not significantly associated with major hospitalization-requiring cardiovascular events (HR 1.03, 95% CI 0.90-1.18, p=0.66) in adults without prior cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: